David Beasley, PhD

Associate Director, World Health Organization Collaborating Center

  • 3786 Citations
  • 36 h-Index
1997 …2024

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2003

West Nile encephalitis

Solomon, T., Ooi, M. H., Beasley, D. W. C. & Mallewa, M., Apr 19 2003, In : British Medical Journal. 326, 7394, p. 865-869 5 p.

Research output: Contribution to journalReview article

106 Scopus citations

West Nile Virus in Mexico: Evidence of Widespread Circulation since July 2002

Estrada-Franco, J. G., Navarro-Lopez, R., Beasley, D. W. C., Coffey, L., Carrara, A. S., Da Rosa, A. T., Clements, T., Wang, E., Ludwig, G. V., Campomanes Cortes, A., Paz Ramirez, P., Tesh, R. B., Barrett, A. D. T. & Weaver, S. C., Dec 2003, In : Emerging infectious diseases. 9, 12, p. 1604-1607 4 p.

Research output: Contribution to journalReview article

Open Access
128 Scopus citations
2004

Molecular determinants of virulence of West Nile virus in North America.

Beasley, D. W., Davis, C. T., Whiteman, M., Granwehr, B., Kinney, R. M. & Barrett, A. D., 2004, In : Archives of virology. Supplementum. 18, p. 35-41 7 p.

Research output: Contribution to journalReview article

59 Scopus citations
2005

Recent advances in the molecular biology of West Nile virus

Beasley, D. W. C., Dec 1 2005, In : Current molecular medicine. 5, 8, p. 835-850 16 p.

Research output: Contribution to journalReview article

45 Scopus citations
2008

Current use and development of vaccines for Japanese encephalitis

Beasley, D. W. C., Lewthwaite, P. & Solomon, T., Jan 1 2008, In : Expert Opinion on Biological Therapy. 8, 1, p. 95-106 12 p.

Research output: Contribution to journalReview article

69 Scopus citations
2011

Safety and immunogenicity of a chimeric vaccine for West Nile virus in aged subjects

Beasley, D. W. C., May 1 2011, In : Expert review of vaccines. 10, 5, p. 601-604 4 p.

Research output: Contribution to journalReview article

3 Scopus citations

Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus

Beasley, D. W., Feb 1 2011, In : Immunotherapy. 3, 2, p. 269-285 17 p.

Research output: Contribution to journalReview article

51 Scopus citations
2015

Yellow fever virus: Genetic and phenotypic diversity and implications for detection, prevention and therapy

Beasley, D. W. C., McAuley, A. J. & Bente, D. A., Mar 2015, In : Antiviral research. 115, p. 48-70 23 p.

Research output: Contribution to journalReview article

34 Scopus citations
2016

First vaccine approval under the FDA Animal Rule

Beasley, D., Brasel, T. L. & Comer, J., Aug 25 2016, In : npj Vaccines. 1, 16013.

Research output: Contribution to journalReview article

11 Scopus citations

Research and development of Zika virus vaccines

Dawes, B. E., Smalley, C. A., Tiner, B. L., Beasley, D., Milligan, G., Reece, L. M., Hombach, J. & Barrett, A., Jul 28 2016, In : npj Vaccines. 1, 16007.

Research output: Contribution to journalReview article

15 Scopus citations
2018

Current status of Severe Fever with Thrombocytopenia Syndrome vaccine development

Reece, L. M., Beasley, D., Milligan, G., Sarathy, V. & Barrett, A., Apr 1 2018, In : Current Opinion in Virology. 29, p. 72-78 7 p.

Research output: Contribution to journalReview article

6 Scopus citations